TradingScreen integrates Bondcliq data
TradingScreen, the order and execution management system (OEMS) provider, has partnered and integrated with TradingScreen,, the corporate bond market system. The integration of BondCliQ’s...
Viewpoint : Best execution : Constantinos Antoniades & Rebecca Healey
A global gold standard of best execution – moving beyond MiFID II
By Constantinos Antoniades, Head of Fixed Income, and Rebecca Healey, Head of EMEA...
Credit : Information overload : Dan Barnes
Dealer axes: Can’t see the wood for the trees
A proliferation of axes and inventories are making dealer data hard to consume by trading desks....
On the DESK : Cathy Gibson : Royal London
The buy side must be an active participant in shaping market structure if investors are to achieve the best returns, says Cathy Gibson.
Biography: Cathy...
Industry viewpoint : Trading U.S. Treasuries : Josh Holden
Beige:
US Treasuries path forward likely to be moulded by lessons of other markets
By Josh Holden,
Chief Information Officer, OpenDoor Trading
At OpenDoor we recently celebrated the...
Viewpoint : The impact of technology : Mike du Plessis & Mark Goodman
AI angst: keeping up with the robots
By Mike du Plessis, Managing Director, Global Head FX, Rates and Credit Execution Services and Mark Goodman, Managing...
Lead : Crossing trades & best execution : Dan Barnes
The best ways to cross‑trade
Crossing trades between funds is operationally complex but rewarding for investors and asset managers; using platforms to standardise the process...
Rates : Trading protocols : Dan Barnes
The new Treasuries protocols
Breaking away from the request-for-quote protocol could allow for tighter pricing without information leakage.
Traders engaged in the US Treasury (UST) markets...
CME to buy NEX Group
CME to buy NEX Group
CME Group will acquire NEX in a deal expected to close in the second half of 2018, pending approval by...
Derivatives : Exchange-traded products : Joel Clark
Why listed derivatives struggle to address risk
Some traders have been critical of listed products designed to replicate OTC derivatives, but exchanges are working hard...
